Bill Johanson

Bill Johanson

Senior Immuno Oncology Specialist @ Bristol Myers Squibb

About Bill Johanson

Bill Johanson is a Senior Immuno-Oncology Specialist at Bristol-Myers Squibb in the Greater Seattle Area, with a diverse background in sales and management roles across the healthcare industry.

Company

Bill Johanson is employed by Bristol-Myers Squibb, working as a Senior Immuno-Oncology Specialist in the Greater Seattle Area, including Eastern Washington and Alaska. Bristol-Myers Squibb is known for developing innovative medicines for patients with serious diseases, particularly in the field of oncology.

Title

Bill Johanson holds the position of Senior Immuno-Oncology Specialist. His role involves specialized focus on immuno-oncology therapies, contributing to the development and sales of treatments for various cancers.

Education and Expertise

Bill Johanson earned a Bachelor of Arts in Physical Education/Exercise Physiology and a Master of Arts in Physical Education/Sports Medicine from the University of the Pacific. This educational background provides a strong foundation in both the physical aspects of human biology and the application of medical treatments in sports and exercise settings.

Background

Bill Johanson has an extensive career in the medical and pharmaceutical industry. He has worked with several notable companies, including Allergan, Novartis, Berlex Laboratories, and others. His roles have ranged from Territory Business Manager to Key Account Manager and Executive Neuroscience Specialist. He also has experience managing clinics and serving on the board of the Northwest Parkinson's Foundation.

Achievements

Bill Johanson has been recognized for his outstanding performance multiple times. He finished 2019 as the top performer in his peer group in the West Region and won the Winner’s Circle Award for the West Region in 2017 and the National At-Large Winner’s Circle Award in 2020. He has also played a significant role in launching key oncology products such as Opdivo for melanoma, non-small cell lung cancer, and renal cell carcinoma, as well as combinations like Opdivo+Yervoy.

People similar to Bill Johanson